Ochsner Academics Names First Recipient of Endowed JOHVI Distinguished Scholar in Cardiovascular Innovation
RELEASE DATE: June 11, 2021
Ochsner Academics is pleased to announce Hernan Bazan, MD, DFSVS, FACS has been selected as the first awardee of the newly established John Ochsner Heart and Vascular Institute Distinguished Scholar in Cardiovascular Innovation. The award provides funds to protect time dedicated to developing innovation in clinical care, research, or the training of physicians.
The endowment will support Dr. Bazan’s research study entitled “Innovation in Acute Carotid Stroke Treatments to Prevent Atherosclerotic Plaque Rupture.”
Dr. Bazan is Section Head of Vascular/Endovascular Surgery in the Department of Surgery at Ochsner Health. He is also Program Director for the Vascular Surgery Fellowship at Ochsner and Professor-Faculty of Medicine with The University of Queensland. Dr. Bazan joined Ochsner in 2008, is Board-certified in vascular surgery, and author of over 45 peer-reviewed publications.
“The Endowed JOHVI Distinguished Scholar in Cardiovascular Innovation honors the legacy of Dr. John Ochsner and his commitment to impacting patient care. It reflects the tradition and importance of endowed scholars in recognizing and fostering excellence in innovative patient care among physicians and scientists,” said Leo Seoane, MD, Chief Academic Officer at Ochsner Health.
“The holder of this distinguished scholar position is receiving one of the most prestigious honors that can be bestowed upon an Ochsner Health physician,” said W. Mark Roberts, MD, Dean of Research, Ochsner Health. “Dr. Bazan is well-deserving as our first recipient with his exemplary track record of accomplishment in patient care, education, research, and innovation in cardiovascular care,” he added.
Dr. Bazan completed undergraduate work at Vanderbilt University and medical school training at Georgetown University. He was a Howard Hughes Medical Institutes Research Scholar at the National Institutes of Health while in medical school. General surgery training was performed at The Mount Sinai Hospital where he was awarded the Arthur H. Aufses, Sr. Prize in Surgery. A vascular surgery fellowship was completed at Yale University.
Dr. Bazan has received multiple teaching awards by medical students and fellow surgical residents. He has an active atherosclerosis translational research program on the mechanisms involved in carotid plaque rupture and stroke, is the co-founder of a life sciences company aimed treating chronic pain thru safer novel non-narcotic molecules, and a biotechnology company developing unique neuroprotection strategies for acute stroke.
Dr. Bazan’s Endowed JOHVI Distinguished Scholar in Cardiovascular Innovation Award begins on July 1, 2021 and continues through to June 30, 2026.